The co-expression profile of PXR and P-gp in the peripheral blood mononuclear cells of non-small cell lung cancer (NSCLC) patients has been used as biomarker for predicting paclitaxel resistance 120. The gene discussed is PGP; the disease is non-small cell lung carcinoma.